⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
globenewswire.com
LGND
Form 8-K
sec.gov
LGND
LGNDZ
LGNZZ
LGNXZ
LGNYZ
Form 8-K
sec.gov
XOMAP
XOMAO
XOMA
LGND
XOMA Royalty Announces Closing of Its Acquisition by Ligand
globenewswire.com
LGND
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
globenewswire.com
LGND
Form 8-K
sec.gov
LGNXZ
LGNYZ
LGND
LGNDZ
LGNZZ
Ligand Announces Closing of Convertible Senior Notes Offering
globenewswire.com
LGND
Ligand Announces Pricing of Upsized $625 Million Convertible Senior Notes Offering
globenewswire.com
LGND
Form 8-K
sec.gov
LGNXZ
LGND
LGNYZ
LGNDZ
LGNZZ
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031
globenewswire.com
LGND